• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

The Top Line
Podcast

Behind the headlines of ASCO 2026

Fierce’s Darren Incorvaia, Zoey Becker and Angus Liu break down the biggest takeaways from ASCO 2026.
Ayla Ellison , Angus Liu , Zoey Becker , Darren Incorvaia Jun 5, 2026 9:38am
Food and Drug Administration

Regulatory tracker: AbbVie's Elahere cleared for use in England

Jun 5, 2026 9:25am
How HER2 biology is shaping next-generation cancer treatment

How HER2 biology is shaping next-generation cancer treatment

Brought to you by Jazz Pharmaceuticals
china chinese Asia

China's biotech rise; ASCO highlights—Fierce Pharma Asia

Jun 5, 2026 8:30am
Top Line Podcast - ZS

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS
The Supreme Court building

In a big win for generics drugmakers, SCOTUS sides with Hikma

Jun 4, 2026 3:11pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings